Thromb Haemost 78:1067–1078ĭempfle CE, Zips S, Ergul H, Heene DL, and the FACT Study Group (2001) Evaluation of 23 quantitative D-dimer assays as basis for the development of D-dimer calibrators. Pfitzner SA, Dempfle CE, Heene DL (1997) Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A. Walker JB, Nesheim ME (1999) The molecular weights, mass distribution, chain composition, and structure of soluble fibrin degradation products released from fibrin clot perfused with plasmin. REF 00454, 24552 02-Edition October 2003ĭempfle CE (2003) Evaluation of a new automated quantitative D-dimer, advanced D-dimer, in patients suspected of venous thromboembolism: a comment on correlation of D-dimer assays. 9)ĭiagnostica Stago D-DI test package insert. Quantitative D-dimer for the exclusion of venous thromboembolic disease (2010) Proposed Guideline H59-P, Vol 30(No. Thromb Res 118:569–571ĪMAX Accuclot D-Dimer product insert No. New Engl J Med 288:633ĭempfle CE (2006) D-Dimer assays: the current status and new assay technologies. Lippincott Williams & Wilkins, Philadelphia, PA, pp 383–386Įllman L, Carvalho A et al (1973) The Thrombo-Wellcotest as a screening test for disseminated intravascular coagulation. In: Loscalzo J, Schafer AI (eds) Thrombosis and hemorrhage. Churchill Livingstone Elsevier, Edinburgh, p 386īockenstedt PL (2003) Laboratory methods in hemostasis. In: Lewis SM, Bain BJ, Bates I (eds) Dacie & Lewis practical haematology, 10th edn. Laffan M, Manning R (2006) Investigation of haemostasis. TB Lippincott Company, Philadelphia, PA, pp 1081–1083 In: Colman RW, Hirsch J, Marder VJ (eds) Hemostasis and thrombosis: basic principles and clinical practice, 3rd edn. p 115įrancis CW, Marder VJ (1994) Physiologic regulation and pathologic disorders of fibrinolysis. BJH 60(4):715–722Īdam SS, Key NS, Greenberg CS (2009) D-dimer antigen: current concepts and future prospects. Hunt FA, Rylatt DB, Hart RA, Bundesen PG (1985) Serum crosslinked fibrin (XDP) and fibrinogen/fibrin degradation products (FDP) in disorders associated with activation of the coagulation of fibrinolytic systems.
0 kommentar(er)
